Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled Clinical Trial of Methotrexate (MTX) in the Treatment of Advanced Knee Osteoarthritis With Effusion-synovitis

NCT03815448 is registered in ClinicalTrials.gov with Zhujiang Hospital as lead sponsor.

NCT NCT03815448
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03815448 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled Clinical Trial of Methotrexate (MTX) in the Treatment of Advanced Knee Osteoarthritis With Effusion-synovitis
Lead sponsor
Zhujiang Hospital
Phase
Not applicable
Overall status
Completed
Start date
July 18, 2019
Completion date
December 1, 2023
Enrollment
215 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

effusion synovial, knee osteoarthritis, knee pain